Parasites enter the eye through hematogenous spread. The interaction with host immune system may result in its destruction but not without collateral damage to the vital retinal structures. Currently, the accepted treatment for ocular parasitosis is surgical removal or direct laser photocoagulation. A 24-year-old Indian woman presented with abrupt painless loss of vision to 5/300. A large yellow-white lesion centered at macula was observed with associated retinal and subretinal hemorrhage and neurosensory retinal detachment. A parasite was seen protruding at the center of the lesion. Fluorescein angiography demonstrated disc leakage and vessel wall staining. Ultrasonography demonstrated a highly reflective subretinal lesion with aftershadowing. Serological test was positive for anti-cysticercus (IgM) antibody. Treatment with prednisolone and albendazole resulted in resolution of the lesion within 2 months with improvement of visual acuity to 20/400. A noncystic form of subretinal cysticercosis is likely with suggestive B-scan ultrasonography and serological investigations.
Introduction
Parasites transit the vascular tunic of eye prior to entering the subretinal or intraocular space. Host immune response triggered by the parasite antigens may incite inflammation of the ocular structures. According to Lech, " to leave the parasite in the eye is to condemn the patient to blindness or total loss of the eye" [1] . The treatment advocated is urgent surgical removal or direct laser photocoagulation of the live parasite. Surgical removal of parasite from the subretinal space is complex and would necessitate performing a retinotomy. Laser photocoagulation needs precision and can be complicated by increased inflammation and development of scotoma when placed in the macula. Antihelminthic therapy for intraocular parasite carries risk of systemic adverse effects, limited effectiveness, and exacerbation of intraocular inflammation. Prior or concurrent administration of corticosteroids may help reduce the worsening of inflammation induced by the death of parasite. Monitoring of liver function and blood counts is essential if long-term antihelminthic therapy is contemplated.
We report a case of submacular live parasite masquerading as posterior pole granuloma treated with systemic antihelminthics and corticosteroids. was negative for Toxoplasma and Toxocara but positive for anti-cysticercus (IgM) antibody. Treatment was initiated with prednisolone 60 mg per day to be tapered by 10 mg per day every week. Albendazole 400 mg twice daily for 2 weeks was advised to be started from day 3 of therapy. Ten days following the instituted therapy, the subretinal lesion appeared to be organized with reduced subretinal fluid and associated vasculitis (supplementary figure file in Supplementary Material available online at http://dx.doi.org/10.1155/2015/910383). A dense white (opaque) plaque-like lesion located at the site of motile parasite was observed with no activity indicating the response to albendazole therapy (Figure 1(d) ). The uveitis remained quiescent and the patient's vision improved to 20/400 over the next 2 months. The status remained unchanged over 4 years of follow-up.
Case Description

Discussion
Our region is endemic to some parasites particularly cysticercosis [2] . Cysticercus larva may rarely present without its characteristic cystic form. Nainiwal et al. have reported with histopathological confirmation of a free-floating live cysticercus larva removed from the vitreous cavity [3] . Wender et al. reported 8 (36.4%) eyes of patients who presented with ruptured cyst; four of them were located in the subretinal space [4] . It is possible that the disruption of cyst wall and extrusion of its contents induced severe granulomatous reaction in our patient. The ultrasonographic appearance of calcification in our case supports a possible diagnosis of subretinal cysticercus larva. The lack of fluid-filled sac however did not provide the classic sonographic demonstration. Inflammation induced by the cystic contents of cysticercosis may be severe.
Case Reports in Ophthalmological Medicine 3 Agarwal et al. reported a case of intraocular cysticercosis simulating retinoblastoma in a 5-year-old child [5] . The lack of neuroradiological and histopathological evidence fails to corroborate the diagnosis of a subretinal cysticercus larva. The importance of serological investigation in an endemic region for a disease is debatable [6] . Moreover, the prohibitive cost and limited utility as a guide for treatment restrict its general use. In our case, the result of serological tests provided some corroborative evidence. Surgical removal of cyst in toto is the accepted treatment for intraocular cysticercosis. However, in our case the atypical manifestation and submacular location precluded a safe removal of the parasite. The specific location of the parasite at the macula amidst subretinal exudates in an inflamed eye limits the options of surgical and laser therapy. Lim and Chee successfully treated a subretinal cysticercosis with use of albendazole coupled with immunosuppressive dose of oral steroids [7] . Our case illustrates that a high index of suspicion in a patient from endemic region, a detailed examination under high magnification, and investigations may provide a clue to the diagnosis. The management with albendazole and oral corticosteroids helped in abolishing the parasite in our patient's eye without any further complication.
